ロード中...
Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure
BACKGROUND: Beta-blocker therapy has become a mainstay therapy for the over 5 million patients with chronic heart failure in the United States. Variation in clinical response to β-blockers is a well-known phenomenon and may be because of genetic differences between patients. We hypothesized that var...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3035051/ https://ncbi.nlm.nih.gov/pubmed/18953265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e328317cc57 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|